IDXX存量在超过预期收入和提升2025年指南后达到52周的高水平。 IDXX stock hit a 52-week high after beating earnings expectations and raising 2025 guidance.

2025年11月3日,IDEXX实验室(IDXX)在报告第三季度收入(每股3.40美元)超过3.14美元的共识和11.05亿美元收入(13.3%)之后,于2025年11月3日飙升到52周的最高水平,为733.52美元。 IDEXX Laboratories (IDXX) surged to a 52-week high of $733.52 on November 3, 2025, after reporting third-quarter earnings of $3.40 per share—exceeding the $3.14 consensus—and $1.105 billion in revenue, up 13.3% year-over-year. 该公司将2025年的收入指导提高到每股12.81美元至13.01美元,预测收入为4.27美元至4.3亿美元,说明其伙伴动物组、牲畜和奶制品以及水测试部门业绩良好。 The company raised its 2025 earnings guidance to $12.81–$13.01 per share and revenue forecast to $4.27–$4.30 billion, citing strong performance across its Companion Animal Group, livestock and dairy, and water testing segments. 分析家的反应是好坏参半,但普遍是正面的,包括从Stifel和Morgan Stanley升级,而股票的市场上限达到584.1亿美元,业绩优于关键移动平均数。 Analysts responded with mixed but generally positive ratings, including upgrades from Stifel and Morgan Stanley, while the stock’s market cap reached $58.41 billion and it outperformed key moving averages.